Literature DB >> 21991905

Ipilimumab plus dacarbazine in melanoma.

Michael G Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21991905     DOI: 10.1056/NEJMc1108661

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

Authors:  Camille Guillerey; Lucas Ferrari de Andrade; Slavica Vuckovic; Kim Miles; Shin Foong Ngiow; Michelle C R Yong; Michele W L Teng; Marco Colonna; David S Ritchie; Marta Chesi; Martha Chesi; P Leif Bergsagel; Geoffrey R Hill; Mark J Smyth; Ludovic Martinet
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.